{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:27:57Z","timestamp":1794288477861,"version":"4.9.0"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12026-022-09351-3","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T07:03:03Z","timestamp":1672297383000},"page":"422-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["In silico design and evaluation of a novel mRNA vaccine against BK virus: a reverse vaccinology approach"],"prefix":"10.1007","volume":"71","author":[{"given":"Yasaman","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8103-2685","authenticated-orcid":false,"given":"Navid","family":"Nezafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manica","family":"Negahdaripour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedigheh","family":"Eskandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhdeh","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,29]]},"reference":[{"issue":"7712","key":"9351_CR1","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0140-6736(71)91776-4","volume":"297","author":"S Gardner","year":"1971","unstructured":"Gardner S, et al. New human papovavirus (BK) isolated from urine after renal transplantation. The Lancet. 1971;297(7712):1253\u20137.","journal-title":"The Lancet"},{"key":"9351_CR2","doi-asserted-by":"crossref","unstructured":"Polz, D., A. Stec, and M. Polz-Dacewicz, BK-virus (BKV)\u2013structure, epidemiology and pathogenesis. Journal of Pre-Clinical and Clinical Research, 2013. 7(2).","DOI":"10.26444\/jpccr\/71451"},{"issue":"5","key":"9351_CR3","first-page":"283","volume":"5","author":"R M\u00e4ntyj\u00e4rvi","year":"1973","unstructured":"M\u00e4ntyj\u00e4rvi R, et al. A human papovavirus (BK), biological properties and seroepidemiology. Ann Clin Res. 1973;5(5):283\u20137.","journal-title":"Ann Clin Res"},{"issue":"6","key":"9351_CR4","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/infdis\/128.6.784","volume":"128","author":"KV Shah","year":"1973","unstructured":"Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis. 1973;128(6):784\u20137.","journal-title":"J Infect Dis"},{"issue":"4","key":"9351_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1099\/00222615-7-4-543","volume":"7","author":"M Portolani","year":"1974","unstructured":"Portolani M, et al. Prevalence in Italy of antibodies to a new human papovavirus (BK virus). J Med Microbiol. 1974;7(4):543\u20136.","journal-title":"J Med Microbiol"},{"issue":"5845","key":"9351_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/bmj.1.5845.77","volume":"1","author":"SD Gardner","year":"1973","unstructured":"Gardner SD. Prevalence in England of antibody to human polyomavirus (BK). Br Med J. 1973;1(5845):77\u20138.","journal-title":"Br Med J"},{"issue":"42","key":"9351_CR7","doi-asserted-by":"publisher","first-page":"7031","DOI":"10.1038\/sj.onc.1207920","volume":"23","author":"D Das","year":"2004","unstructured":"Das D, Shah RB, Imperiale MJ. Detection and expression of human BK virus sequences in neoplastic prostate tissues. Oncogene. 2004;23(42):7031\u201346.","journal-title":"Oncogene"},{"issue":"1","key":"9351_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/jmv.10450","volume":"71","author":"WA Knowles","year":"2003","unstructured":"Knowles WA, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol. 2003;71(1):115\u201323.","journal-title":"J Med Virol"},{"issue":"1","key":"9351_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-82160-0","volume":"11","author":"J McCaffrey","year":"2021","unstructured":"McCaffrey J, Bhute VJ, Shenoy M. BK virus infection and outcome following kidney transplantation in childhood. Sci Rep. 2021;11(1):1\u20138.","journal-title":"Sci Rep"},{"key":"9351_CR10","doi-asserted-by":"crossref","unstructured":"Knowles, W.A., Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Polyomaviruses and human diseases, 2006: p. 19\u201345.","DOI":"10.1007\/0-387-32957-9_2"},{"key":"9351_CR11","doi-asserted-by":"crossref","unstructured":"Corallini, A., et al., Evidence for BK virus as a human tumor virus. Human polyomaviruses: molecular and clinical perspectives, 2001: p. 431\u201360.","DOI":"10.1002\/0471221945.ch16"},{"issue":"2","key":"9351_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1128\/CMR.00074-16","volume":"30","author":"GR Ambalathingal","year":"2017","unstructured":"Ambalathingal GR, et al. BK polyomavirus: clinical aspects, immune regulation, and emerging therapies. Clin Microbiol Rev. 2017;30(2):503\u201328.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"9351_CR13","first-page":"59","volume":"8","author":"M Portolani","year":"1985","unstructured":"Portolani M, et al. Restricted replication of BK virus in human lymphocytes. Microbiologica. 1985;8(1):59\u201366.","journal-title":"Microbiologica"},{"issue":"1","key":"9351_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1128\/AEM.66.1.238-245.2000","volume":"66","author":"S Bofill-Mas","year":"2000","unstructured":"Bofill-Mas S, Pina S, Girones R. Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl Environ Microbiol. 2000;66(1):238\u201345.","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"9351_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/(SICI)1096-9071(200003)60:3<353::AID-JMV16>3.0.CO;2-R","volume":"60","author":"M Chatterjee","year":"2000","unstructured":"Chatterjee M, Weyandt TB, Frisque RJ. Identification of archetype and rearranged forms of BK virus in leukocytes from healthy individuals. J Med Virol. 2000;60(3):353\u201362.","journal-title":"J Med Virol"},{"issue":"12","key":"9351_CR16","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1002\/jmv.21923","volume":"82","author":"R Boldorini","year":"2010","unstructured":"Boldorini R, et al. BK virus sequences in specimens from aborted fetuses. J Med Virol. 2010;82(12):2127\u201332.","journal-title":"J Med Virol"},{"issue":"5","key":"9351_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1348-0421.1975.tb00897.x","volume":"19","author":"F Taguchi","year":"1975","unstructured":"Taguchi F, et al. Transplacental transmission of BK virus in human. Jpn J Microbiol. 1975;19(5):395\u20138.","journal-title":"Jpn J Microbiol"},{"issue":"4","key":"9351_CR18","first-page":"299","volume":"29","author":"F Taguchi","year":"1985","unstructured":"Taguchi F, Kajioka J, Shimada N. Presence of interferon and antibodies to BK virus in amniotic fluid of normal pregnant women. Acta Virol. 1985;29(4):299\u2013304.","journal-title":"Acta Virol"},{"issue":"3","key":"9351_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jinf.2020.06.009","volume":"81","author":"A Saade","year":"2020","unstructured":"Saade A, Styczynski J, Cesaro S. BK virus infection in allogeneic hematopoietic cell transplantation: an update on pathogenesis, immune responses, diagnosis and treatments. J Infect. 2020;81(3):372\u201382.","journal-title":"J Infect"},{"issue":"2","key":"9351_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/jmv.1890100203","volume":"10","author":"J Goudsmit","year":"1982","unstructured":"Goudsmit J, et al. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol. 1982;10(2):91\u20139.","journal-title":"J Med Virol"},{"issue":"2","key":"9351_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/ndt\/gfu023","volume":"30","author":"D Sawinski","year":"2015","unstructured":"Sawinski D, Goral S. BK virus infection: an update on diagnosis and treatment. Nephrol Dial Transplant. 2015;30(2):209\u201317.","journal-title":"Nephrol Dial Transplant"},{"key":"9351_CR22","first-page":"71","volume":"94","author":"K D\u00f6rries","year":"1998","unstructured":"D\u00f6rries K. Molecular biology and pathogenesis of human polyomavirus infections. Dev Biol Stand. 1998;94:71\u20139.","journal-title":"Dev Biol Stand"},{"key":"9351_CR23","unstructured":"Shah, K. and P. Howley, Papillomaviruses. Virology. 1995, Raven Press Ltd., New York."},{"issue":"2","key":"9351_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1086\/321813","volume":"33","author":"MD Reploeg","year":"2001","unstructured":"Reploeg MD, Storch GA, Clifford DB. BK virus: a clinical review. Clin Infect Dis. 2001;33(2):191\u2013202.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"9351_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2215\/CJN.02021205","volume":"1","author":"CB Drachenberg","year":"2006","unstructured":"Drachenberg CB, Papadimitriou JC, Ramos E. Histologic versus molecular diagnosis of BK polyomavirus\u2013associated nephropathy: a shifting paradigm? Clin J Am Soc Nephrol. 2006;1(3):374\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"9351_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00042560-199606010-00006","volume":"12","author":"L Vago","year":"1996","unstructured":"Vago L, et al. JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects Study of 41 cases and review of the literature. J Acquir Immune Defic Syndr. 1996;12(2):139\u201346.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"9351_CR27","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5694\/mja12.10072","volume":"198","author":"KL Daveson","year":"2013","unstructured":"Daveson KL, et al. BK virus-associated progressive multifocal leukoencephalopathy. Med J Aust. 2013;198(4):216\u20138.","journal-title":"Med J Aust"},{"issue":"3","key":"9351_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0035-3787(05)85040-4","volume":"161","author":"L Cabrejo","year":"2005","unstructured":"Cabrejo L, et al. Progressive BK virus associated multifocal leukoencephalopathy in an immunocompromised patient treated with corticosteroids. Revue Neurologique. 2005;161(3):326\u201330.","journal-title":"Revue Neurologique"},{"issue":"1","key":"9351_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/00007890-199901150-00018","volume":"67","author":"PS Randhawa","year":"1999","unstructured":"Randhawa PS, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney1. Transplantation. 1999;67(1):103\u20139.","journal-title":"Transplantation"},{"issue":"4","key":"9351_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/0272-6386(95)90608-8","volume":"26","author":"R Purighalla","year":"1995","unstructured":"Purighalla R, et al. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis. 1995;26(4):671\u20133.","journal-title":"Am J Kidney Dis"},{"issue":"24","key":"9351_CR31","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.2146\/ajhp160585","volume":"74","author":"AD Santeusanio","year":"2017","unstructured":"Santeusanio AD, Lukens BE, Eun J. Antiviral treatment of BK virus viremia after kidney transplantation. Am J Health Syst Pharm. 2017;74(24):2037\u201345.","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"9351_CR32","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/ndt\/gfn675","volume":"24","author":"S-W Wu","year":"2009","unstructured":"Wu S-W, Chang H-R, Lian J-D. The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients. Nephrol Dial Transplant. 2009;24(3):1034\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"9351_CR33","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","volume":"5","author":"DC Brennan","year":"2005","unstructured":"Brennan DC, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant. 2005;5(3):582\u201394.","journal-title":"Am J Transplant"},{"issue":"11","key":"9351_CR34","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.vaccine.2018.01.065","volume":"36","author":"P Pezzotti","year":"2018","unstructured":"Pezzotti P, et al. The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900\u20132015. Vaccine. 2018;36(11):1435\u201343.","journal-title":"Vaccine"},{"key":"9351_CR35","doi-asserted-by":"crossref","unstructured":"Tomar, N. and R.K. De, Immunoinformatics: a brief review. Immunoinformatics, 2014: p. 23\u201355.","DOI":"10.1007\/978-1-4939-1115-8_3"},{"issue":"3","key":"9351_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1556\/amicr.61.2014.3.4","volume":"61","author":"S Khalili","year":"2014","unstructured":"Khalili S, et al. Computational vaccinology and epitope vaccine design by immunoinformatics. Acta Microbiol Immunol Hung. 2014;61(3):285\u2013307.","journal-title":"Acta Microbiol Immunol Hung"},{"key":"9351_CR37","first-page":"3","volume":"2","author":"R Mar\u00eda","year":"2017","unstructured":"Mar\u00eda R, et al. The impact of bioinformatics on vaccine design and development. Vaccines. 2017;2:3\u20136.","journal-title":"Vaccines"},{"issue":"1","key":"9351_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova IA, Flower DR. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 2007;8(1):1\u20137.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"9351_CR39","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.vaccine.2006.09.032","volume":"25","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova IA, Flower DR. Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties. Vaccine. 2007;25(5):856\u201366.","journal-title":"Vaccine"},{"issue":"23","key":"9351_CR40","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","volume":"26","author":"CN Magnan","year":"2010","unstructured":"Magnan CN, et al. High-throughput prediction of protein antigenicity using protein microarray data. Bioinformatics. 2010;26(23):2936\u201343.","journal-title":"Bioinformatics"},{"issue":"W1","key":"9351_CR41","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson B, et al. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 2020;48(W1):W449\u201354.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"9351_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0969-2126(00)00026-5","volume":"2","author":"LJ Stern","year":"1994","unstructured":"Stern LJ, Wiley DC. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure. 1994;2(4):245\u201351.","journal-title":"Structure"},{"issue":"9","key":"9351_CR43","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0198-8859(02)00432-9","volume":"63","author":"PA Reche","year":"2002","unstructured":"Reche PA, Glutting J-P, Reinherz EL. Prediction of MHC class I binding peptides using profile motifs. Hum Immunol. 2002;63(9):701\u20139.","journal-title":"Hum Immunol"},{"issue":"10","key":"9351_CR44","doi-asserted-by":"publisher","first-page":"e1003266","DOI":"10.1371\/journal.pcbi.1003266","volume":"9","author":"JJ Calis","year":"2013","unstructured":"Calis JJ, et al. Properties of MHC class I presented peptides that enhance immunogenicity. PLoS Comput Biol. 2013;9(10):e1003266.","journal-title":"PLoS Comput Biol"},{"issue":"9","key":"9351_CR45","doi-asserted-by":"publisher","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"S Gupta","year":"2013","unstructured":"Gupta S, et al. In silico approach for predicting toxicity of peptides and proteins. Plos One. 2013;8(9):e73957.","journal-title":"Plos One"},{"issue":"6","key":"9351_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov I, et al. AllerTOP v. 2\u2014a server for in silico prediction of allergens. J Mol Model. 2014;20(6):1\u20136.","journal-title":"J Mol Model"},{"key":"9351_CR47","doi-asserted-by":"crossref","unstructured":"Dimitrov, I., D.R. Flower, and I. Doytchinova. AllerTOP-a server for in silico prediction of allergens. in BMC bioinformatics. 2013. BioMed Central.","DOI":"10.1186\/1471-2105-14-S6-S4"},{"issue":"6","key":"9351_CR48","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/bioinformatics\/btt619","volume":"30","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov I, et al. AllergenFP: allergenicity prediction by descriptor fingerprints. Bioinformatics. 2014;30(6):846\u201351.","journal-title":"Bioinformatics"},{"issue":"1","key":"9351_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-10-296","volume":"10","author":"M Nielsen","year":"2009","unstructured":"Nielsen M, Lund O. NN-align An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics. 2009;10(1):1\u201310.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"9351_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-8-238","volume":"8","author":"M Nielsen","year":"2007","unstructured":"Nielsen M, Lundegaard C, Lund O. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics. 2007;8(1):1\u201312.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"9351_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-7580-4-2","volume":"4","author":"J Sidney","year":"2008","unstructured":"Sidney J, et al. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res. 2008;4(1):1\u201314.","journal-title":"Immunome Res"},{"issue":"6","key":"9351_CR52","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/9858","volume":"17","author":"T Sturniolo","year":"1999","unstructured":"Sturniolo T, et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol. 1999;17(6):555\u201361.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"9351_CR53","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00251-015-0873-y","volume":"67","author":"M Andreatta","year":"2015","unstructured":"Andreatta M, et al. Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification. Immunogenetics. 2015;67(11):641\u201350.","journal-title":"Immunogenetics"},{"issue":"1","key":"9351_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6150-8-30","volume":"8","author":"SK Dhanda","year":"2013","unstructured":"Dhanda SK, Vir P, Raghava GP. Designing of interferon-gamma inducing MHC class-II binders. Biol Direct. 2013;8(1):1\u201315.","journal-title":"Biol Direct"},{"key":"9351_CR55","doi-asserted-by":"crossref","unstructured":"Dhanda, S.K., et al., Prediction of IL4 inducing peptides. Clinical and Developmental Immunology, 2013. 2013.","DOI":"10.1155\/2013\/263952"},{"issue":"1","key":"9351_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep42851","volume":"7","author":"G Nagpal","year":"2017","unstructured":"Nagpal G, et al. Computer-aided designing of immunosuppressive peptides based on IL-10 inducing potential. Sci Rep. 2017;7(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"W1","key":"9351_CR57","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","volume":"45","author":"MC Jespersen","year":"2017","unstructured":"Jespersen MC, et al. BepiPred-20: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 2017;45(W1):W24-w29.","journal-title":"Nucleic Acids Res"},{"key":"9351_CR58","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/1471-2105-8-361","volume":"8","author":"HH Bui","year":"2007","unstructured":"Bui HH, et al. Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinformatics. 2007;8:361.","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"9351_CR59","doi-asserted-by":"publisher","first-page":"D464","DOI":"10.1093\/nar\/gky1004","volume":"47","author":"SK Burley","year":"2019","unstructured":"Burley SK, et al. RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy. Nucleic Acids Res. 2019;47(D1):D464\u201374.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"9351_CR60","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, et al. The protein data bank. Nucleic Acids Res. 2000;28(1):235\u201342.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"9351_CR61","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkw329","volume":"44","author":"A Lamiable","year":"2016","unstructured":"Lamiable A, et al. PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex. Nucleic Acids Res. 2016;44(W1):W449\u201354.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"9351_CR62","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1021\/ct500592m","volume":"10","author":"Y Shen","year":"2014","unstructured":"Shen Y, et al. Improved PEP-FOLD approach for peptide and miniprotein structure prediction. J Chem Theory Comput. 2014;10(10):4745\u201358.","journal-title":"J Chem Theory Comput"},{"issue":"W1","key":"9351_CR63","doi-asserted-by":"publisher","first-page":"W288","DOI":"10.1093\/nar\/gks419","volume":"40","author":"P Th\u00e9venet","year":"2012","unstructured":"Th\u00e9venet P, et al. PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides. Nucleic Acids Res. 2012;40(W1):W288-93.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"9351_CR64","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, et al. The ClusPro web server for protein\u2013protein docking. Nat Protoc. 2017;12(2):255\u201378.","journal-title":"Nat Protoc"},{"key":"9351_CR65","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-7-153","volume":"7","author":"HH Bui","year":"2006","unstructured":"Bui HH, et al. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics. 2006;7:153.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"9351_CR66","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0092-8674(86)90762-2","volume":"44","author":"M Kozak","year":"1986","unstructured":"Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell. 1986;44(2):283\u201392.","journal-title":"Cell"},{"issue":"11","key":"9351_CR67","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.4161\/rna.22269","volume":"9","author":"T Schlake","year":"2012","unstructured":"Schlake T, et al. Developing mRNA-vaccine technologies. RNA Biol. 2012;9(11):1319\u201330.","journal-title":"RNA Biol"},{"issue":"3","key":"9351_CR68","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.biosystems.2005.05.005","volume":"81","author":"Q Liu","year":"2005","unstructured":"Liu Q. Comparative analysis of base biases around the stop codons in six eukaryotes. Biosystems. 2005;81(3):281\u20139.","journal-title":"Biosystems"},{"issue":"19","key":"9351_CR69","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1016\/j.vaccine.2003.12.030","volume":"22","author":"KM Lima","year":"2004","unstructured":"Lima KM, et al. Vaccine adjuvant: it makes the difference. Vaccine. 2004;22(19):2374\u20139.","journal-title":"Vaccine"},{"issue":"D1","key":"9351_CR70","doi-asserted-by":"publisher","first-page":"D506","DOI":"10.1093\/nar\/gky1049","volume":"47","author":"Consortium U","year":"2019","unstructured":"Consortium U. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47(D1):D506\u201315.","journal-title":"Nucleic Acids Res"},{"key":"9351_CR71","doi-asserted-by":"crossref","unstructured":"Gasteiger, E., et al., Protein identification and analysis tools on the ExPASy server. The proteomics protocols handbook, 2005: p. 571\u2013607.","DOI":"10.1385\/1-59259-890-0:571"},{"issue":"4","key":"9351_CR72","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1006\/jmbi.2002.5425","volume":"317","author":"S Maurer-Stroh","year":"2002","unstructured":"Maurer-Stroh S, Eisenhaber B, Eisenhaber F. N-terminal N-myristoylation of proteins: refinement of the sequence motif and its taxon-specific differences. J Mol Biol. 2002;317(4):523\u201340.","journal-title":"J Mol Biol"},{"issue":"3","key":"9351_CR73","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1006\/jmbi.1999.3069","volume":"292","author":"B Eisenhaber","year":"1999","unstructured":"Eisenhaber B, Bork P, Eisenhaber F. Prediction of potential GPI-modification sites in proprotein sequences. J Mol Biol. 1999;292(3):741\u201358.","journal-title":"J Mol Biol"},{"issue":"12","key":"9351_CR74","doi-asserted-by":"publisher","first-page":"5634","DOI":"10.1038\/s41596-021-00628-9","volume":"16","author":"Z Du","year":"2021","unstructured":"Du Z, et al. The trRosetta server for fast and accurate protein structure prediction. Nat Protoc. 2021;16(12):5634\u201351.","journal-title":"Nat Protoc"},{"key":"9351_CR75","doi-asserted-by":"crossref","unstructured":"Su, H., et al., Improved protein structure prediction using a new multi\u2010scale network and homologous templates. Advanced Science, 2021: p. 2102592.","DOI":"10.1002\/advs.202102592"},{"issue":"3","key":"9351_CR76","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1073\/pnas.1914677117","volume":"117","author":"J Yang","year":"2020","unstructured":"Yang J, et al. Improved protein structure prediction using predicted interresidue orientations. Proc Natl Acad Sci. 2020;117(3):1496\u2013503.","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"9351_CR77","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"C Colovos","year":"1993","unstructured":"Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 1993;2(9):1511\u20139.","journal-title":"Protein Sci"},{"issue":"5016","key":"9351_CR78","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1126\/science.1853201","volume":"253","author":"JU Bowie","year":"1991","unstructured":"Bowie JU, L\u00fcthy R, Eisenberg D. A method to identify protein sequences that fold into a known three-dimensional structure. Science. 1991;253(5016):164\u201370.","journal-title":"Science"},{"issue":"6364","key":"9351_CR79","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/356083a0","volume":"356","author":"R L\u00fcthy","year":"1992","unstructured":"L\u00fcthy R, Bowie JU, Eisenberg D. Assessment of protein models with three-dimensional profiles. Nature. 1992;356(6364):83\u20135.","journal-title":"Nature"},{"issue":"2","key":"9351_CR80","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski RA, et al. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr. 1993;26(2):283\u201391.","journal-title":"J Appl Crystallogr"},{"issue":"2","key":"9351_CR81","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 2007;35(2):W407\u201310.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"9351_CR82","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/prot.340170404","volume":"17","author":"MJ Sippl","year":"1993","unstructured":"Sippl MJ. Recognition of errors in three-dimensional structures of proteins: Proteins Struct Funct Bioinforma. 1993;17(4):355\u201362.","journal-title":"Proteins Struct Funct Bioinforma"},{"key":"9351_CR83","first-page":"396","volume-title":"Methods in enzymology","author":"D Eisenberg","year":"1997","unstructured":"Eisenberg D, L\u00fcthy R, Bowie JU. [20] VERIFY3D: assessment of protein models with three-dimensional profiles. In: Methods in enzymology. Elsevier; 1997. p. 396\u2013404."},{"issue":"23","key":"9351_CR84","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","volume":"32","author":"LC Xue","year":"2016","unstructured":"Xue LC, et al. PRODIGY: a web server for predicting the binding affinity of protein\u2013protein complexes. Bioinformatics. 2016;32(23):3676\u20138.","journal-title":"Bioinformatics"},{"issue":"1","key":"9351_CR85","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/prot.21495","volume":"69","author":"N Andrusier","year":"2007","unstructured":"Andrusier N, Nussinov R, Wolfson HJ. FireDock fast interaction refinement in molecular docking. Proteins Struct Funct Bioinforma. 2007;69(1):139\u201359.","journal-title":"Proteins Struct Funct Bioinforma"},{"issue":"2","key":"9351_CR86","doi-asserted-by":"publisher","first-page":"W229","DOI":"10.1093\/nar\/gkn186","volume":"36","author":"E Mashiach","year":"2008","unstructured":"Mashiach E, et al. FireDock: a web server for fast interaction refinement in molecular docking. Nucleic Acids Res. 2008;36(2):W229\u201332.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"9351_CR87","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/pro.3289","volume":"27","author":"RA Laskowski","year":"2018","unstructured":"Laskowski RA, et al. PDBsum: structural summaries of PDB entries. Protein Sci. 2018;27(1):129\u201334.","journal-title":"Protein Sci"},{"issue":"W1","key":"9351_CR88","doi-asserted-by":"publisher","first-page":"W271","DOI":"10.1093\/nar\/gku339","volume":"42","author":"JR L\u00f3pez-Blanco","year":"2014","unstructured":"L\u00f3pez-Blanco JR, et al. iMODS: internal coordinates normal mode analysis server. Nucleic Acids Res. 2014;42(W1):W271\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"9351_CR89","doi-asserted-by":"publisher","first-page":"W70","DOI":"10.1093\/nar\/gkn188","volume":"36","author":"AR Gruber","year":"2008","unstructured":"Gruber AR, et al. The vienna RNA websuite. Nucleic Acids Res. 2008;36(2):W70\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"9351_CR90","doi-asserted-by":"publisher","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin N, et al. Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. Plos One. 2010;5(4):e9862.","journal-title":"Plos One"},{"key":"9351_CR91","doi-asserted-by":"publisher","first-page":"842329","DOI":"10.1155\/2012\/842329","volume":"2012","author":"F Castiglione","year":"2012","unstructured":"Castiglione F, et al. How the interval between prime and boost injection affects the immune response in a computational model of the immune system. Comput Math Methods Med. 2012;2012:842329.","journal-title":"Comput Math Methods Med"},{"key":"9351_CR92","doi-asserted-by":"crossref","unstructured":"Walker, J.M., The proteomics protocols handbook. 2005: Springer.","DOI":"10.1385\/1592598900"},{"issue":"6","key":"9351_CR93","first-page":"1895","volume":"88","author":"A Ikai","year":"1980","unstructured":"Ikai A. Thermostability and aliphatic index of globular proteins. J Biochem. 1980;88(6):1895\u20138.","journal-title":"J Biochem"},{"issue":"26","key":"9351_CR94","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1016\/j.vaccine.2019.04.096","volume":"37","author":"V Kesherwani","year":"2019","unstructured":"Kesherwani V, Tarang S. An immunoinformatic approach to universal therapeutic vaccine design against BK virus. Vaccine. 2019;37(26):3457\u201363.","journal-title":"Vaccine"},{"issue":"12","key":"9351_CR95","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1128\/CVI.00290-09","volume":"16","author":"SA Plotkin","year":"2009","unstructured":"Plotkin SA. Vaccines: the fourth century. Clin Vaccine Immunol. 2009;16(12):1709\u201319.","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"9351_CR96","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/pharmaceutics8010007","volume":"8","author":"S Tandrup Schmidt","year":"2016","unstructured":"Tandrup Schmidt S, et al. Liposome-based adjuvants for subunit vaccines: formulation strategies for subunit antigens and immunostimulators. Pharmaceutics. 2016;8(1):7.","journal-title":"Pharmaceutics"},{"issue":"3","key":"9351_CR97","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/vaccines2030515","volume":"2","author":"W Li","year":"2014","unstructured":"Li W, et al. Peptide vaccine: progress and challenges. Vaccines. 2014;2(3):515\u201336.","journal-title":"Vaccines"},{"key":"9351_CR98","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ijbiomac.2020.06.213","volume":"162","author":"I Ahammad","year":"2020","unstructured":"Ahammad I, Lira SS. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach. Int J Biol Macromol. 2020;162:820\u201337.","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"9351_CR99","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1586\/erv.09.77","volume":"8","author":"L Redding","year":"2009","unstructured":"Redding L, Weiner DB. DNA vaccines in veterinary use. Expert Rev Vaccines. 2009;8(9):1251\u201376.","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"9351_CR100","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1046\/j.1365-3024.2000.00304.x","volume":"22","author":"R Harrison","year":"2000","unstructured":"Harrison R, Bianco A. DNA immunization with Onchocerca volvulus genes, Ov-tmy-1 and OvB20: serological and parasitological outcomes following intramuscular or GeneGun delivery in a mouse model of onchocerciasis. Parasite Immunol. 2000;22(5):249\u201357.","journal-title":"Parasite Immunol"},{"issue":"4","key":"9351_CR101","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, et al. mRNA vaccines \u2014 a new era in vaccinology. Nat Rev Drug Discov. 2018;17(4):261\u201379.","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"9351_CR102","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","volume":"16","author":"K Karik\u00f3","year":"2008","unstructured":"Karik\u00f3 K, et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther. 2008;16(11):1833\u201340.","journal-title":"Mol Ther"},{"key":"9351_CR103","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jconrel.2015.12.032","volume":"240","author":"KJ Kauffman","year":"2016","unstructured":"Kauffman KJ, Webber MJ, Anderson DG. Materials for non-viral intracellular delivery of messenger RNA therapeutics. J Control Release. 2016;240:227\u201334.","journal-title":"J Control Release"},{"issue":"3","key":"9351_CR104","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/gt.2017.5","volume":"24","author":"S Guan","year":"2017","unstructured":"Guan S, Rosenecker J. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems. Gene Ther. 2017;24(3):133\u201343.","journal-title":"Gene Ther"},{"issue":"9","key":"9351_CR105","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/mt.2015.103","volume":"23","author":"A Thess","year":"2015","unstructured":"Thess A, et al. Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals. Mol Ther. 2015;23(9):1456\u201364.","journal-title":"Mol Ther"},{"issue":"21","key":"9351_CR106","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1093\/nar\/gkr695","volume":"39","author":"K Kariko","year":"2011","unstructured":"Kariko K, et al. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res. 2011;39(21):e142\u2013e142.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"9351_CR107","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","volume":"13","author":"U Sahin","year":"2014","unstructured":"Sahin U, Karik\u00f3 K, T\u00fcreci \u00d6. mRNA-based therapeutics\u2014developing a new class of drugs. Nat Rev Drug Discov. 2014;13(10):759\u201380.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"9351_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CJI.0b013e3181f7dbe8","volume":"34","author":"M Fotin-Mleczek","year":"2011","unstructured":"Fotin-Mleczek M, et al. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity. J Immunother. 2011;34(1):1\u201315.","journal-title":"J Immunother"},{"issue":"10","key":"9351_CR109","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/clinchem\/48.10.1647","volume":"48","author":"NB Tsui","year":"2002","unstructured":"Tsui NB, Ng EK, Lo YD. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem. 2002;48(10):1647\u201353.","journal-title":"Clin Chem"},{"issue":"5","key":"9351_CR110","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/iub.1625","volume":"69","author":"N Chen","year":"2017","unstructured":"Chen N, et al. RNA sensors of the innate immune system and their detection of pathogens. IUBMB Life. 2017;69(5):297\u2013304.","journal-title":"IUBMB Life"},{"issue":"12","key":"9351_CR111","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/nbt.2436","volume":"30","author":"B Petsch","year":"2012","unstructured":"Petsch B, et al. Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection. Nat Biotechnol. 2012;30(12):1210\u20136.","journal-title":"Nat Biotechnol"},{"issue":"36","key":"9351_CR112","doi-asserted-by":"publisher","first-page":"14604","DOI":"10.1073\/pnas.1209367109","volume":"109","author":"AJ Geall","year":"2012","unstructured":"Geall AJ, et al. Nonviral delivery of self-amplifying RNA vaccines. Proc Natl Acad Sci. 2012;109(36):14604\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"7644","key":"9351_CR113","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature21428","volume":"543","author":"N Pardi","year":"2017","unstructured":"Pardi N, et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. 2017;543(7644):248\u201351.","journal-title":"Nature"},{"issue":"1","key":"9351_CR114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13037-020-00273-3","volume":"15","author":"P Anand","year":"2021","unstructured":"Anand P, Stahel VP. Review the safety of Covid-19 mRNA vaccines: a review. Patient Saf Surg. 2021;15(1):1\u20139.","journal-title":"Patient Saf Surg"},{"key":"9351_CR115","doi-asserted-by":"publisher","first-page":"108021","DOI":"10.1016\/j.intimp.2021.108021","volume":"99","author":"M Negahdaripour","year":"2021","unstructured":"Negahdaripour M, et al. Administration of COVID-19 vaccines in immunocompromised patients. Int Immunopharmacol. 2021;99:108021.","journal-title":"Int Immunopharmacol"},{"issue":"19","key":"9351_CR116","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMoa066092","volume":"357","author":"IJ Amanna","year":"2007","unstructured":"Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357(19):1903\u201315.","journal-title":"N Engl J Med"},{"issue":"12","key":"9351_CR117","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1093\/infdis\/jiz374","volume":"221","author":"BW Kareko","year":"2020","unstructured":"Kareko BW, et al. Persistence of neutralizing antibody responses among yellow fever virus 17D vaccinees living in a nonendemic setting. J Infect Dis. 2020;221(12):2018\u201325.","journal-title":"J Infect Dis"},{"issue":"11","key":"9351_CR118","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1084\/jem.20032083","volume":"199","author":"B Combadiere","year":"2004","unstructured":"Combadiere B, et al. Distinct time effects of vaccination on long-term proliferative and IFN-\u03b3\u2013producing T cell memory to smallpox in humans. J Exp Med. 2004;199(11):1585\u201393.","journal-title":"J Exp Med"},{"key":"9351_CR119","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fimmu.2014.00171","volume":"5","author":"S Rosendahl Huber","year":"2014","unstructured":"Rosendahl Huber S, et al. T cell responses to viral infections\u2013opportunities for peptide vaccination. Front Immunol. 2014;5:171.","journal-title":"Front Immunol"},{"issue":"2","key":"9351_CR120","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1128\/JVI.75.2.654-660.2001","volume":"75","author":"U Dittmer","year":"2001","unstructured":"Dittmer U, et al. Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection. J Virol. 2001;75(2):654\u201360.","journal-title":"J Virol"},{"issue":"6","key":"9351_CR121","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1359-6101(02)00044-8","volume":"13","author":"DA Chesler","year":"2002","unstructured":"Chesler DA, Reiss CS. The role of IFN-\u03b3 in immune responses to viral infections of the central nervous system. Cytokine Growth Factor Rev. 2002;13(6):441\u201354.","journal-title":"Cytokine Growth Factor Rev"},{"key":"9351_CR122","doi-asserted-by":"crossref","unstructured":"Rojas, J.M., et al., IL-10: a multifunctional cytokine in viral infections. Journal of immunology research, 2017. 2017.","DOI":"10.1155\/2017\/6104054"},{"key":"9351_CR123","doi-asserted-by":"crossref","unstructured":"Luckheeram, R.V., et al., CD4+ T cells: differentiation and functions. Clinical and developmental immunology, 2012. 2012.","DOI":"10.1155\/2012\/925135"},{"issue":"3","key":"9351_CR124","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.immuni.2007.09.002","volume":"27","author":"T D\u00f6rner","year":"2007","unstructured":"D\u00f6rner T, Radbruch A. Antibodies and B cell memory in viral immunity. Immunity. 2007;27(3):384\u201392.","journal-title":"Immunity"},{"issue":"7","key":"9351_CR125","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1084\/jem.192.7.953","volume":"192","author":"RK Do","year":"2000","unstructured":"Do RK, et al. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med. 2000;192(7):953\u201364.","journal-title":"J Exp Med"},{"key":"9351_CR126","unstructured":"Janeway Jr, C.A., et al., B-cell activation by armed helper T cells, in Immunobiology: the immune system in health and disease. 5th edition. 2001, Garland Science."},{"key":"9351_CR127","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.trivac.2016.04.003","volume":"5","author":"TA Ahmad","year":"2016","unstructured":"Ahmad TA, Eweida AE, Sheweita SA. B-cell epitope mapping for the design of vaccines and effective diagnostics. Trials Vaccinology. 2016;5:71\u201383.","journal-title":"Trials Vaccinology"},{"key":"9351_CR128","doi-asserted-by":"crossref","unstructured":"EL\u2010Manzalawy, Y., D. Dobbs, and V. Honavar, Predicting linear B\u2010cell epitopes using string kernels. Journal of Molecular Recognition: An Interdisciplinary Journal, 2008. 21(4): p. 243\u2013255.","DOI":"10.1002\/jmr.893"},{"issue":"8","key":"9351_CR129","doi-asserted-by":"publisher","first-page":"e104351","DOI":"10.1371\/journal.pone.0104351","volume":"9","author":"SJ Lee","year":"2014","unstructured":"Lee SJ, et al. A potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652 enhances dendritic cells-based tumor immunotherapy. Plos One. 2014;9(8):e104351.","journal-title":"Plos One"},{"issue":"13","key":"9351_CR130","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1182\/blood-2006-04-015024","volume":"108","author":"S Holtkamp","year":"2006","unstructured":"Holtkamp S, et al. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood. 2006;108(13):4009\u201317.","journal-title":"Blood"},{"issue":"15","key":"9351_CR131","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/S0264-410X(02)00740-5","volume":"21","author":"JW Zinckgraf","year":"2003","unstructured":"Zinckgraf JW, Silbart LK. Modulating gene expression using DNA vaccines with different 3\u2032-UTRs influences antibody titer, seroconversion and cytokine profiles. Vaccine. 2003;21(15):1640\u20139.","journal-title":"Vaccine"},{"issue":"10","key":"9351_CR132","first-page":"1486","volume":"7","author":"J Stepinski","year":"2001","unstructured":"Stepinski J, et al. Synthesis and properties of mRNAs containing the novel \u201canti-reverse\u201d cap analogs 7-methyl (3\u2032-O-methyl) GpppG and 7-methyl (3\u2032-deoxy) GpppG. Rna. 2001;7(10):1486\u201395.","journal-title":"Rna"},{"issue":"9","key":"9351_CR133","first-page":"957","volume":"1","author":"A Pasquinelli","year":"1995","unstructured":"Pasquinelli A, Dahlberg JE, Lund E. Reverse 5\u2019caps in RNAs made in vitro by phage RNA polymerases. RNA. 1995;1(9):957\u201367.","journal-title":"RNA"},{"issue":"11","key":"9351_CR134","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1101\/gad.5.11.2108","volume":"5","author":"DR Gallie","year":"1991","unstructured":"Gallie DR. The cap and poly (A) tail function synergistically to regulate mRNA translational efficiency. Genes Dev. 1991;5(11):2108\u201316.","journal-title":"Genes Dev"},{"issue":"1","key":"9351_CR135","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4049\/jimmunol.180.1.309","volume":"180","author":"S Kreiter","year":"2008","unstructured":"Kreiter S, et al. Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals. J Immunol. 2008;180(1):309\u201318.","journal-title":"J Immunol"},{"key":"9351_CR136","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.imlet.2017.07.007","volume":"190","author":"Y Kou","year":"2017","unstructured":"Kou Y, et al. Tissue plasminogen activator (tPA) signal sequence enhances immunogenicity of MVA-based vaccine against tuberculosis. Immunol Lett. 2017;190:51\u20137.","journal-title":"Immunol Lett"},{"issue":"10","key":"9351_CR137","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen X, Zaro JL, Shen W-C. Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev. 2013;65(10):1357\u201369.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"9351_CR138","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/protein\/14.8.529","volume":"14","author":"R Arai","year":"2001","unstructured":"Arai R, et al. Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng. 2001;14(8):529\u201332.","journal-title":"Protein Eng"},{"key":"9351_CR139","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.meegid.2017.02.007","volume":"49","author":"B Meza","year":"2017","unstructured":"Meza B, et al. A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: an in silico approach. Infect Genet Evol. 2017;49:309\u201317.","journal-title":"Infect Genet Evol"},{"issue":"1","key":"9351_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-08842-w","volume":"7","author":"N Khatoon","year":"2017","unstructured":"Khatoon N, Pandey RK, Prajapati VK. Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach. Sci Rep. 2017;7(1):1\u201312.","journal-title":"Sci Rep"},{"issue":"1","key":"9351_CR141","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev.genet.30.1.405","volume":"30","author":"M Hochstrasser","year":"1996","unstructured":"Hochstrasser M. Ubiquitin-dependent protein degradation. Annu Rev Genet. 1996;30(1):405\u201339.","journal-title":"Annu Rev Genet"},{"issue":"6","key":"9351_CR142","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.7150\/ijbs.59233","volume":"17","author":"JW Park","year":"2021","unstructured":"Park JW, et al. mRNA vaccines for COVID-19: what, why and how. Int J Biol Sci. 2021;17(6):1446.","journal-title":"Int J Biol Sci"},{"key":"9351_CR143","unstructured":"Jackson, L.A., et al., An mRNA vaccine against SARS-CoV-2\u2014preliminary report. New England journal of medicine, 2020."},{"key":"9351_CR144","unstructured":"Polack, F.P., et al., Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England journal of medicine, 2020."},{"issue":"17","key":"9351_CR145","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMc2113468","volume":"385","author":"AR Falsey","year":"2021","unstructured":"Falsey AR, et al. SARS-CoV-2 neutralization with BNT162b2 vaccine dose 3. N Engl J Med. 2021;385(17):1627\u20139.","journal-title":"N Engl J Med."},{"key":"9351_CR146","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","volume":"73","author":"MJ Hogan","year":"2022","unstructured":"Hogan MJ, Pardi N. mRNA vaccines in the COVID-19 pandemic and beyond. Annu Rev Med. 2022;73:17\u201339.","journal-title":"Annu Rev Med"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-022-09351-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-022-09351-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-022-09351-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:46:02Z","timestamp":1744209962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-022-09351-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,29]]},"references-count":146,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["9351"],"URL":"https:\/\/doi.org\/10.1007\/s12026-022-09351-3","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,29]]},"assertion":[{"value":"25 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No procedures requiring ethics approval were performed in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}